BioHermes is a high-tech IVD enterprise, founded by a group of scientists trained in the U.S. The history can trace back to the year 2006, when we started to produce obstetric products such as fFN and IGFBP-1 for U.S.-based pregnant women. The significant moment came in 2013 when we acquired the innovative HbA1c testing technology from U.S. based Scripps Laboratories. Such technology eventually enabled us to further develop our current major products, including A1C EZ 2.0, GluCoA1c, A1Cchek Pro, and A1Cchek Express. BioHermes changes the way people perform an HbA1c Test, making it possible for users to monitor HbA1c more frequently at almost any site with much-reducedcost. Today, our products are widely sold in more than 100 countries, and are extensively used in clinics, laboratories, hospitals across the globe.